Functional analysis of 13 GBA mutant Alleles identified in Gaucher disease patients:: Pathogenic changes and "modifier" polymorphisms

被引:74
作者
Montfort, M
Chabás, A
Vilageliu, L
Grinberg, D
机构
[1] Univ Barcelona, Fac Biol, Dept Genet, E-08028 Barcelona, Spain
[2] Corp Sanitaria Clin, Hosp Clin, Inst Bioquim Clin, Barcelona, Spain
关键词
Gaucher disease; GD; GBA; expression studies; baculovirus system;
D O I
10.1002/humu.20043
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Gaucher disease, the most prevalent sphingolipidosis, is caused by the deficient activity of acid beta-glucosidase, mainly due to mutations in the GBA gene. Over 200 mutations have been identified worldwide, more than 25 of which were in Spanish patients. In order to demonstrate causality for Gaucher disease, some of them: c.662C > T (p.P182L), c.680A > G (p.N188S), c.886C > T (p.R257X), c.1054T > C (p.Y313H), c.1093G > A (p.E326K), c.1289C > T (p.P391L), c.1292A > T (p.N3921), c.1322T > C (p.I402T), and the double mutants [c.680A > G; c.1093G > A] ([p.N 188S; p.E326K]) and [c.1448T > C; c.1093G > A] ([p.L444P; p.E326K]), were expressed in Sf9 cells using a baculovirus expression system. Other well-established Gaucher disease mutations, namely c.1226A > G (p.N370S), c.1342G > C (p.D409H), and c.1448T > C (p.L444P), were also expressed for comparison. The levels of residual acid beta-glucosidase activity of the mutant enzymes produced by the cDNAs carrying alleles c.662C > T (p.P182L), c.886C > T (p.R257X), c.1054T > C (p.Y313H), c.1289C > T (p.P391L), and c.1292A > T (p.N392I) were negligible. The c.1226A > G (p.N370S), c.1322T > C (p.I402T), c.1342G > C (p.D409H), c.1448T > C (p.L444P), and [c.1448T > C; c.1093G > A] ([p.L444P; p.E326K]) alleles produced enzymes with levels ranging from 6 to 14% of the wild-type. The three remaining alleles, c.680A > G (p.N188S), c.1093G > A (p.E326K), and [c.680A > G; c.1093G > A] ([p.N188S; p.E326K]), showed higher activity (66.6, 42.7, and 23.2%, respectively). Expression studies revealed that the c.1093G > A (p.E326K) change, which was never found alone in a Gaucher disease-causing allele, when found in a double mutant such as [c.680A > G; c.1093G > A] ([p.N 188S; p.E326K]) and [c.1448T > C; c.1093G > A] ([p.L444P; p.E326K]), decreases activity compared to the activity found for the other mutation alone. These results suggest that c.1093G > A (p.E326K) should be considered a "modifier variant" rather than a neutral polymorphism, as previously considered. Mutation c.680A > G (p.N188S), which produces a mutant enzyme with the highest level of activity, is probably a very mild mutation or another "modifier variant.(C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:567 / 575
页数:9
相关论文
共 36 条
[1]   GAUCHERS-DISEASE VARIANT CHARACTERIZED BY PROGRESSIVE CALCIFICATION OF HEART-VALVES AND UNIQUE GENOTYPE [J].
ABRAHAMOV, A ;
ELSTEIN, D ;
GROSSTSUR, V ;
FARBER, B ;
GLASER, Y ;
HADASHALPERN, I ;
RONEN, S ;
TAFAKJDI, M ;
HOROWITZ, M ;
ZIMRAN, A .
LANCET, 1995, 346 (8981) :1000-1003
[2]   Gaucher disease:: expression and characterization of mild and severe acid β-glucosidase mutations in Portuguese type 1 patients [J].
Amaral, O ;
Marcao, A ;
Miranda, MCS ;
Desnick, RJ ;
Grace, ME .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (02) :95-102
[3]   GLUCOCEREBROSIDASE MUTATIONS IN GAUCHER DISEASE [J].
BEUTLER, E ;
DEMINA, A ;
GELBART, T .
MOLECULAR MEDICINE, 1994, 1 (01) :82-92
[4]  
Beutler E., 2001, METABOLIC MOL BASES, V3, P3635
[5]   UNUSUAL EXPRESSION OF GAUCHERS-DISEASE - CARDIOVASCULAR CALCIFICATIONS IN 3 SIBS HOMOZYGOUS FOR THE D409H MUTATION [J].
CHABAS, A ;
CORMAND, B ;
GRINBERG, D ;
BURGUERA, JM ;
BALCELLS, S ;
MERINO, JL ;
MATE, I ;
SOBRINO, JA ;
GONZALEZDUARTE, R ;
VILAGELIU, L .
JOURNAL OF MEDICAL GENETICS, 1995, 32 (09) :740-742
[6]   Neuronopathic and non-neuronopathic presentation of Gaucher disease in patients with the third most common mutation (D409H) in Spain [J].
Chabas, A ;
Cormand, B ;
Balcells, S ;
GonzalezDuarte, R ;
Casanova, C ;
Colomer, J ;
Vilageliu, L ;
Grinberg, D .
JOURNAL OF INHERITED METABOLIC DISEASE, 1996, 19 (06) :798-800
[7]  
Choy FYM, 1997, AM J MED GENET, V71, P172, DOI 10.1002/(SICI)1096-8628(19970808)71:2<172::AID-AJMG10>3.0.CO
[8]  
2-B
[9]  
Choy FYM, 1996, AM J MED GENET, V65, P184, DOI 10.1002/(SICI)1096-8628(19961028)65:3<184::AID-AJMG3>3.3.CO
[10]  
2-R